Stockhead on MSN47m
In big news week Neurizon secures key orphan status for motor neurone drug in EuropeTwas the week before Christmas and the good news was flowing for clinical stage biotech Neurizon Therapeutics (ASX:NUZ), ...
Highlights: IND application submission to the U.S. Food and Drug Administration (FDA) is a pivotal step in initiating a Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback